| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | B7 H ELISA Kit; B7 H1 ELISA Kit; B7 homolog 1 ELISA Kit; B7-H1 ELISA Kit; B7H ELISA Kit; B7H1 ELISA Kit; CD 274 ELISA Kit; CD274 ELISA Kit; CD274 antigen ELISA Kit; CD274 molecule ELISA Kit; MGC142294 ELISA Kit; MGC142296 ELISA Kit; OTTHUMP00000021029 ELISA Kit; PD L1 ELISA Kit; PD-L1 ELISA Kit; PD1L1_HUMAN ELISA Kit; PDCD1 ligand 1 ELISA Kit; PDCD1L1 ELISA Kit; PDCD1LG1 ELISA Kit; PDL 1 ELISA Kit; PDL1 ELISA Kit; Programmed cell death 1 ligand 1 ELISA Kit; Programmed death ligand 1 ELISA Kit; RGD1566211 ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates, cell lysates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Programmed Death Ligand-1(PD-L1/CD274) is a biological molecule commonly studied in others research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: Q9NZQ7
Biological context
Researchers often monitor Programmed Death Ligand-1(PD-L1/CD274) in serum, plasma, tissue homogenates, and cell lysates to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Programmed Death Ligand-1(PD-L1/CD274) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Programmed Death Ligand-1(PD-L1/CD274) may also appear under names such as B7 H and B7 H1. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Programmed Death Ligand-1(PD-L1/CD274) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Increased opioid consumption in neoadjuvant immunotherapy plus chemotherapy for patients with non‐small‐cell lung cancer: A multicenter, prospective cohort study
K Wang, J Er, Y Zhang, C Song, Y Yu,CNS Neuroscience & Therapeutics,2024
Investigation of Some Biomarkers Associated with Malignant and Benign Prostate Tumors in Iraqi Males
BH Hameedi,Journal of medicine and life,2024
Correlation between PD-1 and sPD-L1 expression levels in peripheral blood of DLBCL patients and their clinicopathological characteristics
L Wang,Cellular and molecular biology,2024
Rastvorljivi programirani smrtni ligand 1 (sPD-L1) i programirani smrtni ligand 1 (sPD-1) kao potencijalni biomarkeri za dijagnozu i prognozu kod pacijenata sa gliomom
S Liu,Journal of Medical Biochemistry,2020
The Clinical Significance of Soluble PD-1 and PD-L1 in Lung Cancer
Taher Abu Hejleh, et al,Critical Reviews in Oncology/Hematology,2019
Matrix metalloproteinase and cytokine profiles from cell co-cultures and their role in oral inflammation and head and neck cancer
Amber Marie Bates.et al,/,2018
SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma
Shao T.et al,Cell Physiol Biochem,2018
Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C
Satoshi Yamagiwa.et al,INT J MED SC,2017
PUB072 Significance of PAK1/CREB Pathway in Lung Adenocarcinoma Oncogenesis
S. Yoon.et al,Thoracic Oncology,2017
PUB071 Circulating Programmed Death Ligand-1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
S. Vecchiarelli.et al,Thoracic Oncology,2017
PUB073 Lung Cancer Screening with LDCT-Results of a Small Cohort Continual Monitoring (Pilot Silesian Study)
S. Szablowska-Siwik.et al,Thoracic Oncology,2017
Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy.
Nukui A.et al,BMC Cancer.,2017
SOLUBLE PROGRAMMED DEATH-1 LIGAND-1 (PD-L1) IS DE-CREASED IN ALLERGIC RHINITIS PATIENT
Mohammad Farhadi.et al,Journal of Advances In Allergy & Immunologic Diseases,2017
PUB070 Rare Actionable Mutations in a Lung Adenocarcinoma Cohort in Brazil
C.G. Ferreira.et al,Thoracic Oncology,2017
Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: Association with extent of skin sclerosis.
Yanaba K.et al,J Dermatol.,2016
Expression of programmed cell death ligand-1 in mastocytosis correlates with disease severity
Rabenhorst A.et al,Journal of Allergy and Clinical Immunology,2016
Soluble Programmed Death 1 (PD-1) IsDecreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis
Birtas Atesoglu E.et al,Clin Appl Thromb Hemost.,2016